The challenges of developing drugs for central nervous system disorders have led some major companies to reduce or discontinue investment in the field, even though the unmet medical need is substantial. How can the wealth of basic research knowledge in neuroscience be successfully translated into new therapies?
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1038/nrd3559 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!